Company intelligence / Profile preview

Valhalla Ventures

Miami, Florida, United Statesvalhalla.ventures ↗

Ownership: Private
Development stage: Other

Overview

Valhalla Ventures is a venture capital firm investing in early-stage technology startups across deeptech sectors including biotech and healthcare. Their Fund I ($66M) launched in 2022 with investments spanning precision medicine, neuro drugs, cell therapy/depletion technologies, spatial biology tools, and more.

Modalities: Small moleculeBiologicPrecision medicine
Industry: Investors

Partnerships

none disclosed specific to pharma/biotech partnerships; as a VC they partner with their portfolio founders.

Beyond the preview

Go deeper on Valhalla Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Valhalla Ventures.

Explore the full profile